Spironolactone is not a weight-loss drug or helpful in weight managementany scale changes are typically due to temporary fluid loss
Glucagon-like Peptide 1 Receptor Agonists, Diabetic Retinopathy and Angiogenesis: The AngioSafe Type 2 Diabetes Study
GLP-1 receptor agonists demonstrate modest but clinically meaningful effects on lipid profiles, though cholesterol reduction is not their primary therapeutic indication
Common symptoms of a lower urinary tract infection (cystitis) include: A persistent, strong urge to urinate A burning sensation or pain when passing urine (dysuria) Passing frequent, small amounts of urine Cloudy, dark, or strong-smelling urine Blood in the urine (haematuria), which may appear pink or red Pelvic discomfort or pressure, particularly in women A feeling of incomplete bladder emptying Upper urinary tract infections (pyelonephritis) , affecting the kidneys, are more serious and may present with additional symptoms such as high fever, chills, nausea, vomiting, and pain in the back, side, or groin
GLP-1 Medications GLP-1 medications that are currently available in the United States include: Dulaglutide - once weekly injections Liraglutide - once daily injections Semaglutide - once weekly injections and once daily pills Tirzepatide - once weekly injections